Smith+Nephew INTELLIO Tablet
K-Number: K221929 · 2022-09-06
ApplicantSmith+Nephew
Decision Date2022-09-06
Product CodeODA
Advisory CommitteeGU
DecisionSubstantially Equivalent
Device Summary
Smith+Nephew INTELLIO Tablet is a medical device manufactured by Smith+Nephew. It received FDA 510(k) clearance on 2022-09-06 under approval number K221929. The device is classified under product code ODA. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.
Frequently Asked Questions
What is the Smith+Nephew INTELLIO Tablet?
Smith+Nephew INTELLIO Tablet is a medical device that received FDA 510(k) clearance on 2022-09-06. It is manufactured by Smith+Nephew. The 510(k) number is K221929.
When was Smith+Nephew INTELLIO Tablet approved by the FDA?
Smith+Nephew INTELLIO Tablet received FDA 510(k) clearance on 2022-09-06, under approval number K221929.
What company makes Smith+Nephew INTELLIO Tablet?
Smith+Nephew INTELLIO Tablet is manufactured by Smith+Nephew.
What is the FDA product code for Smith+Nephew INTELLIO Tablet?
The FDA product code for Smith+Nephew INTELLIO Tablet is ODA.
Related Clinical Trials
Related Devices (Code: ODA)
K153205IDSS ForceTriad Control ModuleBlack Diamond Video, Inc.
K151282core nova Complete Operating Room EndoscopyRichard Wolf Medical Instruments Corp.
K192876INTELLIO Tablet ApplicationSmith & Nephew
K203566Tablet ApplicationSmith & Nephew
K232406KARL STORZ OR1 SCB CONTROL (WU300)Karl Storz SE & CO. KG
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.